SMMT - Summit Therapeutics Inc.


14.94
-0.440   -2.945%

Share volume: 2,431,342
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.31%

PREVIOUS CLOSE
CHG
CHG%

$15.38
-0.44
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 12-31-2024 03-31-2025 09-30-2025 12-31-2025
Fiscal Quarter Q4 2024 Q1 2025 Q3 2025 Q4 2025
Report Date 02-24-2025 05-01-2025 10-20-2025 02-23-2026
Assets
Total Assets 435.560 M 383.822 M 261.729 M 751.182 M
Current Assets 423.750 M 370.751 M 246.466 M 720.301 M
Inventories 0.000 0.000 0.000 0.000
Other Current Assets 557.000 K 0.000 0.000 0.000
Short Term Investments 307.487 M 149.789 M 0.000 488.182 M
Total Receivables 0.000 0.000 0.000 0.000
Current Cash 104.862 M 211.526 M 238.554 M 225.266 M
Total Non-current Assets 0.000 0.000 0.000 0.000
Property Plant Equipment 254.000 K 652.000 K 810.000 K 1.059 M
Other Assets 11.556 M 12.419 M 14.453 M 29.822 M
Intangible Assets 0.000 0.000 0.000 0.000
Goodwill 0.000 0.000 0.000 0.000
Liabilities and shareholders’ equity
Total Liabilities and shareholders’ equity 435.560 M 383.822 M 261.729 M 751.182 M
Total liabilities 46.812 M 39.492 M 69.466 M 92.322 M
Total current liabilities 41.729 M 34.877 M 64.928 M 72.988 M
Accounts Payable 4.636 M 4.994 M 22.245 M 20.292 M
Other liabilities 5.083 M 4.615 M 4.538 M 19.334 M
Current long term debt 0.000 0.000 0.000 0.000
Long term debt 0.000 0.000 0.000 0.000
Other liabilities 5.083 M 4.615 M 4.538 M 19.334 M
Minority interest 0.000 0.000 0.000 0.000
Total Shareholder equity 388.748 M 344.330 M 192.263 M 658.860 M
Common stock 1.606 B 1.624 B 2.270 B 2.956 B
Retained earnings -1.215 B -1.277 B -2.075 B -2.294 B